NEWS

PD-1 blockade exploiting MMR deficiency – Nature.com

Nature.comPD-1 blockade exploiting MMR deficiencyNature.comThese tumours typically harbour thousands of mutations and are postulated to present neoantigens that might be exploited for effective immunotherapy. New data reported by Dung Le et al. support… Continue reading

PD-1 blockade exploiting MMR deficiency – Nature.com

Nature.comPD-1 blockade exploiting MMR deficiencyNature.comThese tumours typically harbour thousands of mutations and are postulated to present neoantigens that might be exploited for effective immunotherapy. New data reported by Dung Le et al. support… Continue reading

Widecells Groups claims landmark as stem cell insurance goes on sale in the UK – Proactive Investors UK

Widecells Groups claims landmark as stem cell insurance goes on sale in the UK – Proactive Investors UK

Driving CAR T-Cell Therapy From Bench to Bedside – Biotechin.Asia

Driving CAR T-Cell Therapy From Bench to BedsideBiotechin.AsiaScientists first began to experiment with CAR T cells in the late 1980s, when a trio of researchers genetically engineered T cells to express a chimeric T cell receptor fused with a variable… Continue reading

Driving CAR T-Cell Therapy From Bench to Bedside – Biotechin.Asia

Driving CAR T-Cell Therapy From Bench to BedsideBiotechin.AsiaScientists first began to experiment with CAR T cells in the late 1980s, when a trio of researchers genetically engineered T cells to express a chimeric T cell receptor fused with a variable… Continue reading